The effectiveness of hand-held digital multimedia presentation of trial information on recruitment and retention of patients to a trial in primary care: an embedded methodology trial protocol
| ISRCTN | ISRCTN12838042 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN12838042 |
| Secondary identifying numbers | SWAT |
- Submission date
- 14/08/2017
- Registration date
- 11/10/2017
- Last edited
- 01/07/2020
- Recruitment status
- Stopped
- Overall study status
- Stopped
- Condition category
- Urological and Genital Diseases
Plain English summary of protocol
Background and study aims
Recruiting patients to studies is a major challenge. Failure to meet recruitment targets can result in delays and underpowered studies. The aim of this study is to assess the effectiveness of a hand-held digital multimedia presentation of study information to potential participants on recruitment and retention to the SATIN study (http://www.isrctn.com/ISRCTN88111427).
Who can participate?
Healthy non-pregnant women visiting participating general practices for a suspected urinary tract infection
What does the study involve?
Participants are randomly allocated to receive either a written participant information leaflet or a multimedia digital information resource, delivered through a handheld tablet device, plus a written participant information leaflet. Participants are invited to ask questions related to participation in the SATIN study. Either the GP or practice nurse completes the SATIN study screening questionnaire. Willing patients are asked to sign an informed consent form and are enrolled into the SATIN study, while patients unwilling to participate are referred back to the GP and receive treatment as per usual clinical practice.
What are the possible benefits and risks of participating?
The results will provide evidence to design effective and comprehensive patient recruitment information. These approaches may be adopted by similar studies in the future. There is no direct benefit to participants. The risks could include spending more time viewing recruitment material.
Where is the study run from?
National University of Ireland Galway (Ireland)
When is the study starting and how long is it expected to run for?
February 2016 to December 2018
Who is funding the study?
Health Research Board (Ireland)
Who is the main contact?
Prof. Declan Devane
Contact information
Public
School of Nursing & Midwifery
Aras Moyola
NUI, Galway
Galway
Galway
Ireland
 ORCID ID |
0000-0002-9393-7075 |
|---|
Study information
| Study design | Two-group parallel randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised parallel trial |
| Study setting(s) | GP practice |
| Study type | Other |
| Participant information sheet | Not available in web format, please use contact details to request a participant information sheet. |
| Scientific title | The effect of a handheld digital multimedia information resource on recruitment and retention of patients to a trial in primary care |
| Study objectives | Studies within trials (SWATs) present an opportunity to examine information on the different design factors that impact the outcome of trials. One area in need of research is trial recruitment. Recruiting patients to trials is a major challenge facing trialists. Failure to meet recruitment targets can result in delays and underpowered studies. This SWAT aims to evaluate the effectiveness of a hand-held digital multimedia presentation of trial information to potential patient participants on recruitment and retention to the host trial (SATIN: http://www.isrctn.com/ISRCTN88111427). |
| Ethics approval(s) | ICGP Ethics Committee, 01/12/2016, ref: ICGP_DEC 2016 |
| Health condition(s) or problem(s) studied | Uncomplicated urinary tract infection |
| Intervention | Eligible patients will be identified by the General Practitioner (GP) within participating practices based on the inclusion and exclusion criteria outlined by SATIN. GPs will invite eligible patients to consider participating in the SATIN trial. Women who have agreed to participate in the SATIN host trial will be randomly allocated by block randomisation to: 1. Comparator: Written participant information leaflet (n=230). This will be written in adherence to good research ethics practice and will invite participation of the women to SATIN. 2. Intervention: Access to multimedia digital information through a handheld tablet device and written participant information leaflet within the general practice (n=230). A handheld, tablet device containing a hard-installed, digital multimedia presentation of the trial information will be given to potential participants. The multimedia presentation of trial information will contain generic information on trial participation and SATIN trial specific content. Following consideration of either the comparator or intervention, women are invited to ask questions related to participation in the SATIN trial. Either the GP or practice nurse completes the SATIN trial screening questionnaire. Willing women are asked to sign an informed consent form and are enrolled into the SATIN trial, patients unwilling to participate are referred back to the GP and receive treatment as per usual clinical practice. The period of follow up is up to 14 days after the participant has viewed the study material. |
| Intervention type | Other |
| Primary outcome measure | The proportion of potentially eligible participants willing to participate in the SATIN trial, calculated as the number of participants who sign the SATIN informed consent form, Measured at 1 year or when trial recruitment has closed |
| Secondary outcome measures | 1. The proportion of participants recruited to the SATIN trial (in case this differs from the number of participants willing to participate, due to e.g. exclusion criteria), recorded in the SATIN electronic case report form (eCRF), measured at 1 year or when trial recruitment has closed 2. The proportion of recruited participants who are retained to the end of the SATIN trial. Retention will be measured as the number of participants who complete the UTI Symptom Score (see SATIN protocol) on days 0-7 and until day 14 or until recovery is achieved, whichever occurs first. Measured at 1 year or when trial recruitment has closed 3. The quality of decision-making, measured through the completion of a decisional scale 2 days after viewing the recruitment material. The scale is adapted from one used within the REFORM trial and drawing conceptually on the SURE and DelibeRATE scales |
| Overall study start date | 01/02/2016 |
| Completion date | 01/12/2018 |
| Reason abandoned (if study stopped) | Objectives no longer viable |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Sex | Female |
| Target number of participants | N = 460 |
| Key inclusion criteria | This SWAT will include healthy, non-pregnant, adult women presenting for consultation for a suspected uncomplicated UTI. The study population are individuals who are being screened for and/or who are eligible to take part in the host SATIN trial. To participate in SWAT-15 individuals must: 1. Be attending a general practice that is taking part in the SATIN trial 2. Have a GP-diagnosed UTI, and at least one of the symptoms dysuria, urinary frequency, or urgency with/without low abdominal pain 3. Be a woman (non-pregnant) aged 18 years or above 4. Be able and willing to give written informed consent 5. Own a smartphone |
| Key exclusion criteria | Key exclusion criteria are as per the SATIN host trial: 1. Any signs of complicated infection or any condition that may lead to complications 2. Current or recent antibiotic use 3. Recent UTI 4. Current intake of NSAIDs 5. Pregnancy or breastfeeding 6. Non-use of highly effective contraception 7. Previous adverse reaction to any of the study drugs 8. Current intake of drugs potentially interacting with the trial drugs 9. Diabetes mellitus, chronic kidney disease or any other previous illness related to kidney or urinary tract 10. History of gastro-intestinal ulcers, Glucose 6 phosphate Dehydrogenase deficiency or any other medical condition that may put the participant at risk or influence the study results in the investigators’ opinion |
| Date of first enrolment | 11/09/2017 |
| Date of final enrolment | 10/09/2018 |
Locations
Countries of recruitment
- Ireland
Study participating centre
-
Ireland
Sponsor information
University/education
Discipline of General Practice
School of Medicine
NUI Galway
Galway
Galway
Ireland
| Website | http://primarycaretrials.ie/ |
|---|---|
"ROR" |
https://ror.org/003hb2249 |
Funders
Funder type
Government
Government organisation / Local government
- Alternative name(s)
- Health Research Board, Ireland, An Bord Taighde Sláinte, HRB
- Location
- Ireland
Results and Publications
| Intention to publish date | 01/12/2019 |
|---|---|
| Individual participant data (IPD) Intention to share | Yes |
| IPD sharing plan summary | Available on request |
| Publication and dissemination plan | The trialists plan to publish the study protocol as soon as the study is registered and publish the results in an open access journal around one year after the overall trial end date. |
| IPD sharing plan | The datasets generated during and/or analysed during the current study are/will be available upon request from Dr Sinead Duane (sinead.duane@nuigalway.ie). |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Protocol article | protocol | 30/03/2020 | 01/07/2020 | Yes | No |
Editorial Notes
01/07/2020: Publication reference added.
04/12/2017: The study was terminated due to termination of the host study on 14/11/2017.
